PHF2 Antikörper (AA 70-82)

Produktnummer ABIN636184

Produktdetails anti-PHF2 Antikörper

Target: PHF2 (PHD Finger Protein 2 (PHF2))

Bindungsspezifität: AA 70-82

Reaktivität: Eukaryonten

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser PHF2 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Aufreinigung: Affinity chromatography purified

Immunogen: PHF2 antibody was raised in rabbit using AA 70-82 [KHGPGPTPDVKRVC] of the 120 kDa PHF protein as the immunogen.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB: 1:500-1:1,000
Optimal conditions should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: Lot specific

Buffer: Affinity purified IgG supplied in PBS with 0.02 % NaN3.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Handhabung: Avoid repeated freeze/thaw cycles.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.

Details zu PHF2

Target: PHF2 (PHD Finger Protein 2 (PHF2))

Andere Bezeichnung: PHF2 (PHF2 Produkte)

Synonyme: CENP-35 antikoerper, GRC5 antikoerper, JHDM1E antikoerper, im:4200679 antikoerper, phf8 antikoerper, wu:fa14c10 antikoerper, PHD finger protein 2 antikoerper, PHF2 antikoerper, Phf2 antikoerper, phf2 antikoerper

Hintergrund: Plant homeodomain (PHD) finger protein 2 (PHF2) is a putative transcription factor. PHF2 contains a zinc finger-like PHD domain that is distinct from other classes of zinc finger motifs and is often found in proteins that influence chromatin structure. It also contains a Jumonji C (JmjC) domain, which may play a role in histone demethylation. The PHF2 gene is ubiquitously expressed in adult mouse tissues, however, the majority of PHF2 expression in the mouse embryo occurs in the neural tube and root ganglia. PHF2 mutations have been associated with both early- and late-onset breast carcinoma.